NewsSonal Adhesives Limited Board Meeting scheduled for May 28, 2026 to approve Q4FY26 and Annual audited financial results under Regulation 29Sonal Adhesives Limited Board Meeting scheduled for May 28, 2026 to approve Q4FY26 and Annual audited financial results under Regulation 29
Sonal Adhesives Limited has officially notified BSE about a board meeting scheduled for May 28, 2026, to approve Q4FY26 and annual audited financial results. The company has implemented trading window restrictions from April 1-30 May for all designated persons under SEBI regulations, with Managing Director Sandeep Arora signing the official notification.
*this image is generated using AI for illustrative purposes only.
Sonal Adhesives Limited has officially notified the Bombay Stock Exchange about an upcoming board meeting scheduled to approve its quarterly and annual audited financial results. The company's Board of Directors will convene on May 28, 2026, to review and approve critical financial documentation for the concluded fiscal year under Regulation 29.
Board Meeting Details
The meeting has been strategically scheduled to address key financial approvals required under regulatory compliance. The board will focus on comprehensive financial review and approval processes during this session, specifically for the audited financial results of the fourth quarter and year ended March 31, 2026.
| Parameter: | Details |
|---|---|
| Meeting Date: | May 28, 2026 |
| Meeting Time: | 4:00 p.m. |
| Primary Agenda: | Audited Financial Results Approval |
| Reporting Period: | Q4 and Year ended March 31, 2026 |
| Exchange Notification: | March 26, 2026 |
Trading Window Restrictions
In accordance with SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, and the company's internal code of conduct, Sonal Adhesives Limited has implemented mandatory trading restrictions. The trading window for dealing in company securities will remain closed for all designated persons, including insiders, from April 1, 2026, to May 30, 2026 (both days inclusive).
Regulatory Compliance
The announcement was formally communicated to the Bombay Stock Exchange on March 26, 2026, ensuring full transparency and regulatory adherence. Managing Director Sandeep Arora (DIN: 00176939) digitally signed the official notification, demonstrating the company's commitment to proper corporate governance protocols. The notification was submitted under the company's scrip code 526901.
Company Information
Sonal Adhesives Limited operates from its registered office located at Plot No. 28/1A, Village Dheku, Takai Adoshi Road, off Khopoli-Pen Road, Taluka Khalapr, District Raigad. The company maintains active communication channels through multiple contact points and continues to uphold its obligations to stakeholders and regulatory bodies under CIN No. L02004MH1991PLC064045.
Historical Stock Returns for Sonal Adhesives
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +7.48% | +3.82% | -0.02% | +17.39% | -8.16% | 0.0% |
What key financial metrics and growth indicators should investors watch for when Sonal Adhesives releases its FY2026 results on May 28?
How might the company's Q4 2026 performance impact its strategic expansion plans in the adhesives market?
Will Sonal Adhesives announce any dividend distribution or bonus share issuance following the board meeting?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
